In summary, we demonstrated that TRIM65 serves as a central oncogene through the activation of YAP1 and up‐regulation of UDP‐GlcNAc and FFA levels, thus promoting the tumor immunosuppressive microenvironment in HCC. The gene discussed is TRIM65; the disease is hepatocellular carcinoma.